ZNF302
gene geneOn this page
Also known as ZNF327ZNF135LZNF140L
Summary
ZNF302 (zinc finger protein 302, HGNC:13848) is a protein-coding gene on chromosome 19q13.11, encoding Zinc finger protein 302 (Q9NR11). May be involved in transcriptional regulation.
This gene encodes a member of the zinc-finger protein family. The encoded protein contains seven C2H2-type zinc fingers and a KRAB domain, but its function has yet to be determined. Alternatively spliced transcript variants have been described.
Source: NCBI Gene 55900 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 77 total
- MANE Select transcript:
NM_001289187
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:13848 |
| Approved symbol | ZNF302 |
| Name | zinc finger protein 302 |
| Location | 19q13.11 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | ZNF327, ZNF135L, ZNF140L |
| Ensembl gene | ENSG00000089335 |
| Ensembl biotype | protein_coding |
| OMIM | 621271 |
| Entrez | 55900 |
Gene structure
Transcript identifiers
Ensembl transcripts: 55 — 52 protein_coding, 3 retained_intron
ENST00000423823, ENST00000446502, ENST00000457781, ENST00000502743, ENST00000505163, ENST00000505242, ENST00000505365, ENST00000506901, ENST00000507959, ENST00000509196, ENST00000509528, ENST00000510002, ENST00000512455, ENST00000613363, ENST00000869116, ENST00000869117, ENST00000869118, ENST00000869119, ENST00000869120, ENST00000869121, ENST00000869122, ENST00000869123, ENST00000869124, ENST00000869125, ENST00000869126, ENST00000869127, ENST00000869128, ENST00000869129, ENST00000869130, ENST00000929232, ENST00000929233, ENST00000929234, ENST00000929235, ENST00000929236, ENST00000929237, ENST00000929238, ENST00000929239, ENST00000929240, ENST00000958495, ENST00000958496, ENST00000958497, ENST00000958498, ENST00000958499, ENST00000958500, ENST00000958501, ENST00000958502, ENST00000958503, ENST00000958504, ENST00000958505, ENST00000958506, ENST00000958507, ENST00000958508, ENST00000958509, ENST00000958510, ENST00000958511
RefSeq mRNA: 15 — MANE Select: NM_001289187
NM_001012320, NM_001289181, NM_001289182, NM_001289183, NM_001289184, NM_001289185, NM_001289186, NM_001289187, NM_001289188, NM_001289189, NM_001289190, NM_001289191, NM_001289192, NM_018443, NM_018675
CCDS: CCDS46042, CCDS74330, CCDS74331, CCDS74332, CCDS74333
Canonical transcript exons
ENST00000505242 — 5 exons
| Exon | Start | End |
|---|---|---|
| ENSE00002032461 | 34677678 | 34678103 |
| ENSE00002033950 | 34684252 | 34686396 |
| ENSE00002492730 | 34682777 | 34682897 |
| ENSE00003637046 | 34683155 | 34683238 |
| ENSE00003709405 | 34678737 | 34678813 |
Expression profiles
Bgee: expression breadth ubiquitous, 285 present calls, max score 97.55.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 16.4253 / max 373.1940, expressed in 1709 samples.
FANTOM5 promoters (3 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 175150 | 13.8531 | 1694 |
| 175151 | 1.9444 | 1006 |
| 175149 | 0.6278 | 290 |
Top tissues by expression
288 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| endothelial cell | CL:0000115 | 97.55 | gold quality |
| sural nerve | UBERON:0015488 | 97.32 | gold quality |
| buccal mucosa cell | CL:0002336 | 97.28 | gold quality |
| cortical plate | UBERON:0005343 | 95.91 | gold quality |
| calcaneal tendon | UBERON:0003701 | 95.19 | gold quality |
| ganglionic eminence | UBERON:0004023 | 94.50 | gold quality |
| germinal epithelium of ovary | UBERON:0001304 | 94.46 | gold quality |
| cerebellar cortex | UBERON:0002129 | 94.21 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 94.21 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 93.90 | gold quality |
| biceps brachii | UBERON:0001507 | 93.77 | gold quality |
| cerebellum | UBERON:0002037 | 93.60 | gold quality |
| body of pancreas | UBERON:0001150 | 93.43 | gold quality |
| ventricular zone | UBERON:0003053 | 93.03 | gold quality |
| left ovary | UBERON:0002119 | 92.99 | gold quality |
| right ovary | UBERON:0002118 | 92.76 | gold quality |
| skeletal muscle tissue of biceps brachii | UBERON:0004502 | 92.67 | gold quality |
| primary visual cortex | UBERON:0002436 | 92.62 | gold quality |
| right uterine tube | UBERON:0001302 | 92.52 | gold quality |
| gastrocnemius | UBERON:0001388 | 92.52 | gold quality |
| muscle of leg | UBERON:0001383 | 92.24 | gold quality |
| muscle layer of sigmoid colon | UBERON:0035805 | 92.22 | gold quality |
| ovary | UBERON:0000992 | 92.15 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 92.11 | gold quality |
| body of uterus | UBERON:0009853 | 92.11 | gold quality |
| thyroid gland | UBERON:0002046 | 91.97 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 91.91 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 91.91 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 91.90 | gold quality |
| lower esophagus muscularis layer | UBERON:0035833 | 91.76 | gold quality |
Single-cell (SCXA)
Detected in 3 experiment(s), a significant marker in 2.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-MTAB-7249 | yes | 10.90 |
| E-ANND-3 | yes | 6.74 |
| E-HCAD-31 | no | 828.89 |
Regulation
Is transcription factor: no
Upstream regulators (CollecTRI, top): STAT1
miRNA regulators (miRDB)
75 targeting ZNF302, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-3925-3P | 100.00 | 69.95 | 1237 |
| HSA-MIR-188-3P | 100.00 | 68.76 | 1240 |
| HSA-MIR-6833-3P | 100.00 | 70.63 | 3197 |
| HSA-MIR-4768-5P | 100.00 | 69.49 | 2861 |
| HSA-MIR-200B-3P | 100.00 | 73.31 | 2693 |
| HSA-MIR-200C-3P | 100.00 | 73.35 | 2685 |
| HSA-MIR-429 | 100.00 | 73.44 | 2698 |
| HSA-LET-7A-3P | 100.00 | 74.03 | 3932 |
| HSA-LET-7B-3P | 100.00 | 74.08 | 3913 |
| HSA-LET-7F-1-3P | 100.00 | 74.02 | 3928 |
| HSA-MIR-98-3P | 100.00 | 74.08 | 3907 |
| HSA-MIR-4262 | 100.00 | 73.26 | 3931 |
| HSA-MIR-433-3P | 99.98 | 69.37 | 1203 |
| HSA-MIR-485-3P | 99.98 | 70.68 | 1585 |
| HSA-MIR-4775 | 99.98 | 75.00 | 6394 |
| HSA-MIR-3692-3P | 99.98 | 70.27 | 2139 |
| HSA-MIR-539-3P | 99.98 | 70.74 | 1616 |
| HSA-MIR-302C-5P | 99.97 | 72.56 | 3642 |
| HSA-MIR-6845-3P | 99.94 | 66.88 | 1439 |
| HSA-MIR-144-3P | 99.94 | 73.98 | 2698 |
| HSA-MIR-3143 | 99.93 | 71.96 | 3104 |
| HSA-MIR-3119 | 99.92 | 71.34 | 2390 |
| HSA-MIR-6809-3P | 99.91 | 71.45 | 3814 |
| HSA-MIR-380-3P | 99.89 | 70.18 | 1978 |
| HSA-LET-7A-2-3P | 99.87 | 70.53 | 1921 |
| HSA-LET-7G-3P | 99.85 | 70.43 | 1929 |
| HSA-MIR-576-5P | 99.84 | 70.46 | 2582 |
| HSA-MIR-4698 | 99.84 | 71.41 | 4303 |
| HSA-MIR-1321 | 99.84 | 65.30 | 1811 |
| HSA-MIR-4739 | 99.84 | 65.25 | 1832 |
Cross-species orthologs
16 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | znf646 | ENSDARG00000061424 |
| danio_rerio | si:dkey-154p10.3 | ENSDARG00000068366 |
| danio_rerio | si:dkey-89b17.4 | ENSDARG00000075545 |
| danio_rerio | zgc:66472 | ENSDARG00000075916 |
| danio_rerio | si:ch211-148l7.4 | ENSDARG00000094469 |
| danio_rerio | znf576.1 | ENSDARG00000097819 |
| drosophila_melanogaster | az2 | FBGN0025185 |
| drosophila_melanogaster | CG2129 | FBGN0030008 |
| drosophila_melanogaster | CG1602 | FBGN0033186 |
| drosophila_melanogaster | CG18011 | FBGN0033491 |
| drosophila_melanogaster | CG12942 | FBGN0033569 |
| drosophila_melanogaster | indra | FBGN0035213 |
| drosophila_melanogaster | CG30020 | FBGN0050020 |
| drosophila_melanogaster | mld | FBGN0263490 |
| caenorhabditis_elegans | ztf-15 | WBGENE00011066 |
| caenorhabditis_elegans | WBGENE00015649 |
Paralogs (36): ZNF184 (ENSG00000096654), CTCF (ENSG00000102974), ZNF574 (ENSG00000105732), ZBTB24 (ENSG00000112365), ZNF142 (ENSG00000115568), CTCFL (ENSG00000124092), ZNF473 (ENSG00000142528), ZNF827 (ENSG00000151612), ZNF689 (ENSG00000156853), ZNF208 (ENSG00000160321), ZNF91 (ENSG00000167232), ZNF526 (ENSG00000167625), ZNF764 (ENSG00000169951), ZNF747 (ENSG00000169955), ZNF282 (ENSG00000170265), ZNF160 (ENSG00000170949), ZNF497 (ENSG00000174586), ZBTB34 (ENSG00000177125), ZNF771 (ENSG00000179965), ZNF48 (ENSG00000180035), ZNF594 (ENSG00000180626), ZBTB37 (ENSG00000185278), ZFP92 (ENSG00000189420), ZNF107 (ENSG00000196247), ZNF729 (ENSG00000196350), ZNF569 (ENSG00000196437), ZNF420 (ENSG00000197050), ZNF785 (ENSG00000197162), ZNF665 (ENSG00000197497), ZNF181 (ENSG00000197841), ZNF347 (ENSG00000197937), ZNF84 (ENSG00000198040), ZBTB48 (ENSG00000204859), ZNF845 (ENSG00000213799), ZNF99 (ENSG00000213973), ZNF688 (ENSG00000229809)
Protein
Protein identifiers
Zinc finger protein 302 — Q9NR11 (reviewed: Q9NR11)
Alternative names: Zinc finger protein 135-like, Zinc finger protein 140-like, Zinc finger protein 327
All UniProt accessions (8): Q9NR11, A0A087WYF4, B4DMN2, D6R9Q0, D6RA23, D6RAM0, E7EVR1, V9GYY2
UniProt curated annotations — full annotation on UniProt →
Function. May be involved in transcriptional regulation.
Subcellular location. Nucleus.
Similarity. Belongs to the krueppel C2H2-type zinc-finger protein family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q9NR11-1 | 1 | yes |
| Q9NR11-2 | 2 |
RefSeq proteins (15): NP_001012320, NP_001276110, NP_001276111, NP_001276112, NP_001276113, NP_001276114, NP_001276115, NP_001276116, NP_001276117, NP_001276118, NP_001276119, NP_001276120, NP_001276121, NP_060913, NP_061145 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001909 | KRAB | Domain |
| IPR013087 | Znf_C2H2_type | Domain |
| IPR036051 | KRAB_dom_sf | Homologous_superfamily |
| IPR036236 | Znf_C2H2_sf | Homologous_superfamily |
Pfam: PF00096, PF01352
UniProt features (16 total): zinc finger region 7, sequence conflict 5, chain 1, domain 1, splice variant 1, cross-link 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9NR11-F1 | 60.12 | 0.04 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (1): 183
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-212436 | Generic Transcription Pathway |
MSigDB gene sets: 129 (showing top):
DELYS_THYROID_CANCER_DN, LIAO_METASTASIS, DING_LUNG_CANCER_EXPRESSION_BY_COPY_NUMBER, JAATINEN_HEMATOPOIETIC_STEM_CELL_UP, KIM_WT1_TARGETS_DN, NUYTTEN_NIPP1_TARGETS_DN, HAMAI_APOPTOSIS_VIA_TRAIL_UP, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, STEIN_ESRRA_TARGETS_RESPONSIVE_TO_ESTROGEN_UP, HORIUCHI_WTAP_TARGETS_UP, ZWANG_DOWN_BY_2ND_EGF_PULSE, CSR_EARLY_UP.V1_DN, GCM_RAB10, SHEN_SMARCA2_TARGETS_UP, GOMF_TRANSCRIPTION_REGULATOR_ACTIVITY
GO Biological Process (2): regulation of transcription by RNA polymerase II (GO:0006357), regulation of DNA-templated transcription (GO:0006355)
GO Molecular Function (6): RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978), DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), zinc ion binding (GO:0008270), DNA binding (GO:0003677), protein binding (GO:0005515), metal ion binding (GO:0046872)
GO Cellular Component (1): nucleus (GO:0005634)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| RNA Polymerase II Transcription | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 2 |
| regulation of DNA-templated transcription | 1 |
| transcription by RNA polymerase II | 1 |
| DNA-templated transcription | 1 |
| regulation of gene expression | 1 |
| regulation of RNA biosynthetic process | 1 |
| cis-regulatory region sequence-specific DNA binding | 1 |
| chromatin | 1 |
| DNA-binding transcription factor activity | 1 |
| regulation of transcription by RNA polymerase II | 1 |
| transition metal ion binding | 1 |
| nucleic acid binding | 1 |
| binding | 1 |
| cation binding | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
0 interactions, top by confidence (×1000):
IntAct
24 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| CEP70 | ZNF302 | psi-mi:“MI:0915”(physical association) | 0.670 |
| ZNF302 | CEP70 | psi-mi:“MI:0915”(physical association) | 0.670 |
| TRIM28 | ZNF316 | psi-mi:“MI:0914”(association) | 0.530 |
| VWCE | ZNF316 | psi-mi:“MI:0914”(association) | 0.530 |
| TRIM28 | ZNF320 | psi-mi:“MI:0914”(association) | 0.530 |
| ZNF302 | NUP210 | psi-mi:“MI:0915”(physical association) | 0.400 |
| ZNF302 | SH3GLB2 | psi-mi:“MI:0915”(physical association) | 0.400 |
| ZNF302 | psi-mi:“MI:0915”(physical association) | 0.370 | |
| ZNF302 | psi-mi:“MI:0915”(physical association) | 0.370 | |
| CLIC1 | ZNF302 | psi-mi:“MI:0915”(physical association) | 0.370 |
| CAND1 | GTPBP10 | psi-mi:“MI:0914”(association) | 0.350 |
| COPS5 | FBLL1 | psi-mi:“MI:0914”(association) | 0.350 |
| CBX5 | ZNF568 | psi-mi:“MI:0914”(association) | 0.350 |
| RFPL4B | KRBA1 | psi-mi:“MI:0914”(association) | 0.350 |
| ZNF302 | DMC1 | psi-mi:“MI:0914”(association) | 0.350 |
| SLC1A3 | DDX11L8 | psi-mi:“MI:0914”(association) | 0.350 |
| EPHA1 | ZNF302 | psi-mi:“MI:0915”(physical association) | 0.000 |
| APP | ZNF302 | psi-mi:“MI:0915”(physical association) | 0.000 |
| RBM11 | ZNF302 | psi-mi:“MI:0915”(physical association) | 0.000 |
| ZNF302 | OPTN | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (33): CEP70 (Two-hybrid), ZNF302 (Two-hybrid), TMEM25 (Affinity Capture-MS), ZNF302 (Affinity Capture-MS), TMEM25 (Affinity Capture-MS), ZNF302 (Affinity Capture-MS), DMC1 (Affinity Capture-MS), KRTAP10-6 (Two-hybrid), ZNF302 (Proximity Label-MS), ZNF302 (Two-hybrid), ZNF302 (Two-hybrid), ZNF302 (Two-hybrid), TMEM25 (Affinity Capture-MS), ZNF302 (Affinity Capture-MS), DMC1 (Affinity Capture-MS)
ESM2 similar proteins: A1KXM5, A1YFC1, A1YGK6, A2T7F2, A7KBS4, B2RXC5, E1JH25, G3X9G7, O96001, P16531, P18748, P34307, P88825, Q2EI21, Q3URU2, Q3V0C1, Q4V8E9, Q5JRM2, Q5R7U0, Q5RDG2, Q5RE50, Q5REF1, Q5SRN2, Q5SS00, Q5U4C1, Q6H236, Q6P1M9, Q6ZN11, Q810T2, Q8BUY8, Q8N3K9, Q8N660, Q8N720, Q8N859, Q8R2V3, Q920R4, Q921B4, Q923B3, Q95JY5, Q96D09
Diamond homologs: A0A1W2PQL4, A6NK75, A6NN14, A6NNF4, A6NP11, A8MQ14, A8MTY0, A8MUV8, A8MXY4, B4DX44, B4DXR9, E9PYI1, O14628, O43345, O75290, O75346, O75373, O75437, O95780, P0CB33, P0DKX0, P0DPD5, P16373, P17019, P17038, P21506, P35789, P52736, P52738, P52744, Q03923, Q03924, Q03936, Q03938, Q05481, Q14586, Q14593, Q14929, Q15928, Q3KNS6
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
77 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 64 |
| Likely benign | 5 |
| Benign | 3 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1435 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 19:34681515:G:GT | donor_gain | 1.0000 |
| 19:34677781:C:G | donor_gain | 0.9900 |
| 19:34677861:GT:G | donor_gain | 0.9900 |
| 19:34678812:AGGTA:A | donor_loss | 0.9900 |
| 19:34678813:GGT:G | donor_loss | 0.9900 |
| 19:34678814:G:T | donor_loss | 0.9900 |
| 19:34678815:T:G | donor_loss | 0.9900 |
| 19:34681483:GGA:G | donor_gain | 0.9900 |
| 19:34681484:G:T | donor_gain | 0.9900 |
| 19:34681490:T:G | donor_gain | 0.9900 |
| 19:34681497:G:GT | donor_gain | 0.9900 |
| 19:34681515:G:T | donor_gain | 0.9900 |
| 19:34681522:G:GT | donor_gain | 0.9900 |
| 19:34681522:G:T | donor_gain | 0.9900 |
| 19:34681576:GCAT:G | donor_gain | 0.9900 |
| 19:34681577:C:T | donor_gain | 0.9900 |
| 19:34681593:G:GT | donor_gain | 0.9900 |
| 19:34681595:A:T | donor_gain | 0.9900 |
| 19:34681632:G:GG | donor_gain | 0.9900 |
| 19:34677883:GGC:G | donor_gain | 0.9800 |
| 19:34678635:C:T | donor_gain | 0.9800 |
| 19:34682771:TTTCA:T | acceptor_loss | 0.9800 |
| 19:34682774:CAG:C | acceptor_loss | 0.9800 |
| 19:34682775:A:T | acceptor_loss | 0.9800 |
| 19:34682893:TGTAG:T | donor_loss | 0.9800 |
| 19:34682896:AGG:A | donor_loss | 0.9800 |
| 19:34682897:GGTAA:G | donor_loss | 0.9800 |
| 19:34682898:G:GT | donor_loss | 0.9800 |
| 19:34682899:T:TC | donor_loss | 0.9800 |
| 19:34677720:C:G | donor_gain | 0.9700 |
AlphaMissense
0 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS1000193422 (19:34681110 C>G), RS1000519672 (19:34682413 TTAGC>T), RS1001348574 (19:34677373 C>A,T), RS1001570216 (19:34686486 A>C,G), RS1002175512 (19:34676665 C>T), RS1002276664 (19:34682358 A>T), RS1002413876 (19:34682090 CAA>C), RS1002519345 (19:34674938 C>A), RS1002522651 (19:34685235 T>C), RS1003054717 (19:34685518 C>G,T), RS1003083281 (19:34678943 T>C), RS1003190905 (19:34675267 G>A), RS1003390299 (19:34686764 C>T), RS1003828094 (19:34680485 C>A), RS1004195176 (19:34676726 T>G)
Disease associations
OMIM: gene MIM:621271 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
27 total (human), top 27 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | decreases expression | 4 |
| GSK-J4 | decreases expression | 1 |
| TAK-243 | increases sumoylation | 1 |
| triphenyl phosphate | affects expression | 1 |
| beta-lapachone | increases expression | 1 |
| sodium arsenite | increases expression | 1 |
| cobaltous chloride | decreases expression | 1 |
| manganese chloride | decreases expression, increases abundance | 1 |
| potassium chromate(VI) | affects cotreatment, decreases expression | 1 |
| ferrous chloride | decreases expression | 1 |
| beta-methylcholine | affects expression | 1 |
| epigallocatechin gallate | affects cotreatment, decreases expression | 1 |
| perfluorooctane sulfonic acid | decreases expression | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| motexafin gadolinium | increases expression | 1 |
| Acetaminophen | decreases expression | 1 |
| Benzene | increases expression | 1 |
| Benzo(a)pyrene | increases methylation | 1 |
| Doxorubicin | decreases expression | 1 |
| Ethyl Methanesulfonate | increases expression | 1 |
| Formaldehyde | increases expression | 1 |
| Manganese | decreases expression, increases abundance | 1 |
| Methyl Methanesulfonate | increases expression | 1 |
| 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide | decreases expression | 1 |
| Aflatoxin M1 | decreases expression | 1 |
| Cadmium Chloride | decreases expression | 1 |
| Zinc Acetate | increases expression | 1 |
Cellosaurus cell lines
1 cell lines: 1 transformed cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_XW31 | HEK293 eGFP-ZNF302 | Transformed cell line | Female |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.